HGHaishan Gao

Haishan Gao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haishan Gao has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mechanistic basis for selective Csm6-2 activation by cyclic penta-adenylate in a type III CRISPR-Cas system

    by Ruyi Shi, Mengquan Yang, Yusong Liu, Haishan Gao, Zhonghui Lin

    Type III CRISPR systems generate cyclic oligoadenylate (cOA, 3 to 6 AMPs) messengers upon detecting viral RNA, activating downstream effectors to defend against viral infection. Although cOA-activated effectors have been extensively characterized, the effectors specific to cA5–one of the most abundant cOA species produced during phage infection–have remained unexplored. Here, we report that the CRISPR ribonuclease Csm6 (Csm6-2) from Actinomyces procaprae selectively employs cA5 as its activator. Csm6-2 utilizes its HEPN domain, rather than the CARF domain, to mediate self-limiting cleavage of cOA activators. Cryo-EM structural analyses reveal that Csm6-2 functions as a homotetramer, and disruption of tetramer formation significantly reduces its ribonuclease activity. Although cA6 and cA5 bind Csm6-2 with comparable affinity, only cA5 induces CARF domain closure, stabilizes the tetramer, and remodels the active site in the HEPN domain. In contrast, the sixth AMP of cA6 imposes significant steric hindrance on CARF domain movement, preventing its closure and subsequent allosteric activation. These findings expand our understanding of the cOA signaling diversity and specific cOA recognition mechanisms in type III CRISPR immunity.


  • Top Cited Papers

    Molecular basis of oocyte cytoplasmic lattice assembly

    by Shuxian Liu, Yusong Liu, Junchao Xue, Zhenzhen Li, Yan Zhang, Bailun Li, Lidan Xu, Lili Li, Zhenzhen Yu, Hongtao Yu, et al.

    Mammalian oocytes are filled by fibric structure called cytoplasmic lattice (CPL), essential for oocyte maturation and early embryonic development1-3. CPL comprises subcortical maternal complex (SCMC) and multiple components, including PADI62,4,5. Despite its discovery in the 1960s, the molecular architecture and assembly mechanisms of CPL have remained poorly understood. Here we present the cryo-electron microscopy (cryo-EM) structure of the CPL isolated from mouse oocytes. Our analysis identified 14 constitutive protein subunits and revealed that CPL is composed of repeating “U-shaped basket” (UB) and “adapter ring” (AR)- featured units, forming a filamentous architecture. AR adopts a two-fold symmetric conformation, containing two NLRP4f, four SCMC and two ZBED3 subunits circularized via two distinct interaction clusters. The UB is anchored by PADI6, a didecamer composed of ten homodimers assembled by two back-to-back pentamers, each forming the lateral side of UB. The underfoot base and up-down sides of the UB are formed by multiple central-symmetric assemblies (UBE2D3-UHRF1-NLRP14) and (TUBB2B-TUBB2A-FBXW24-SKP1) respectively, associating with the PADI6 pentamers to construct the intact UB structure. Two SCMC dimer within each AR connect the up and down sides of two adjacent UBs with an extensive protein-protein interaction network and thus maintain the repetitive connection between the neighboring CPL units. Our work unveils the architectural principles underlying the assembly of this large, periodic CPL filament, offering a molecular basis for understanding CPL’s functions in early mammalian embryogenesis and female reproductive disorders.


  • Open Access

    Aneuploidy of chromosome 8 promotes the mesenchymal lineage during cell fate transitions

    by Cai Liang, Guanchen Li, Qiuqin Zhang, Xinlei Wang, Yu Liu, Wenjuan Yin, Ting Tao, Jinhu Wang, Haishan Gao, Shutao Qi, et al.

    Aneuploidy is present in about 90% human solid tumors. Certain tumors remain addicted to aneuploidy. Paradoxically, artificially induced aneuploidy in normal cells elicits cellular stresses and decreases cell fitness. How aneuploidy initially emerges during tumorigenesis is thus unclear. Using human embryonic stem cells (ESCs) as a model, we show that aneuploid ESCs form immature teratomas with an enrichment of mesenchymal tissues. Specifically, chromosome 8 (chr8) gain, a prevalent form of aneuploidy in human cancers, promotes the expansion of mesenchymal stem cells (MSCs) in teratomas and MSC proliferation in vitro. We further show that human embryonal rhabdomyosarcomas, tumors of mesenchymal origin, lack dominant driver mutations but frequently harbor chr8 gain. Our study suggests a plausible mechanism for aneuploidy emergence during tumorigenesis, links specific aneuploidy to the mesenchymal lineage, and paves the way for identifying vulnerabilities of aneuploid MSCs, which may have important roles in tumorigenesis.


  • Open Access

    Cryo-EM structure of DNA-unbound human MCM2–7 complex reveals new disease-relevant regulation

    by Yusong Liu, Mengquan Yang, Ping Lu, Haishan Gao, Maozhou He, Yitao Wang, Ao Qi, Ting Cao, Qiuqin Zhang, Shutao Qi, et al.

    Chromatin loading of the hexameric replicative helicase MCM2–7 complex requires coordinated interactions with the origin recognition complex (ORC), CDC6, and CDT1. MCM2–7 not bound to DNA forms a single hexamer (SH) with an open DNA entry gate. Two MCM2–7 SHs are loaded sequentially to form the double hexamer (DH) that encircles the DNA duplex. Activated MCM2–7 then unwinds DNA and initiates DNA replication. Our cryo-electron microscopy analyses show that a fraction of human MCM2–7 without DNA exists as DH. Unexpectedly, we find that the MCM3 winged helix domain (WHD) docks on MCM2 in both DNA-free DH and SH, creating a safety latch across the DNA entry gate to block DNA entry into the central channel. The safety latch can be opened by ORC-CDC6 binding. Disrupting this latch by designed or human disease-related mutations of MCM3 causes replication defects and DNA damage checkpoint activation. Our findings uncover a new regulated step in MCM2–7 loading with implications for human diseases.


  • Mechanistic insights into RNA cleavage by human Argonaute2–siRNA complex

    by Zhenzhen Li, Qikui Xu, Yan Zhang, Jing Zhong, Tianxiang Zhang, Junchao Xue, Shuxian Liu, Haishan Gao, Z. Z. Zhao Zhang, Jianping Wu, et al.

    In animals, AGO-clade Argonaute proteins utilize small interfering RNAs (siRNAs) as guides to recognize target with complete complementarity, resulting in target RNA cleavage that is a critical step for target silencing. These proteins feature a constricted nucleic acid-binding channel that limits base pairing between the guide and target beyond the seed region. How the AGO–siRNA complexes overcome this structural limitation and achieve efficient target cleavage remains unclear. We performed cryo-electron microscopy of human AGO–siRNA complexes bound to target RNAs of increasing lengths to examine the conformational changes associated with target recognition and cleavage. Initially, conformational transition propagates from the opening of the PAZ domain and extends through a repositioning of the PIWI–L1–N domain toward the binding channel, facilitating the capture of siRNA–target duplex. Subsequent extension of base pairing drives the downward movement of the PIWI–L1–N domain to enable catalytic activation. Finally, further base pairing toward the 3′ end of siRNA destabilizes the PAZ–N domain, resulting in a “uni-lobed” architecture, which might facilitate the multi-turnover action of the AGO–siRNA enzyme complex. In contrast to PIWI-clade Argonautes, the “uni-lobed” structure of the AGO complex makes multiple contacts with the target in the central region of the siRNA–target duplex, positioning it within the catalytic site. Our findings shed light on the stepwise mechanisms by which the AGO–siRNA complex executes target RNA cleavage and offer insights into the distinct operational modalities of AGO and PIWI proteins in achieving such cleavage.


  • Open Access

    A gate-clamp mechanism for ssDNA translocation by DdmD in Vibrio cholerae plasmid defense

    by Ruoyu Li, Yusong Liu, Haishan Gao, Zhonghui Lin

    The DdmDE antiplasmid system, consisting of the helicase-nuclease DdmD and the prokaryotic Argonaute (pAgo) protein DdmE, plays a crucial role in defending Vibrio cholerae against plasmids. Guided by DNA, DdmE specifically targets plasmids, disassembles the DdmD dimer, and forms a DdmD–DdmE handover complex to facilitate plasmid degradation. However, the precise ATP-dependent DNA translocation mechanism of DdmD has remained unclear. Here, we present cryo-EM structures of DdmD bound to single-stranded DNA (ssDNA) in nucleotide-free, ATPγS-bound, and ADP-bound states. These structures, combined with biochemical analysis, reveal a unique “gate-clamp” mechanism for ssDNA translocation by DdmD. Upon ATP binding, arginine finger residues R855 and R858 reorient to interact with the γ-phosphate, triggering HD2 domain movement. This shift repositions the gate residue Q781, causing a flip of the 3′ flank base, which is then clamped by residue F639. After ATP hydrolysis, the arginine finger releases the nucleotide, inducing HD2 to return to its open state. This conformational change enables DdmD to translocate along ssDNA by one nucleotide in the 5′ to 3′ direction. This study provides new insights into the ATP-dependent translocation of DdmD and contributes to understanding the mechanistic diversity within SF2 helicases.


  • Open Access

    Molecular Basis of VCPIP1 and P97/VCP Interaction Reveals Its Functions in Post‐Mitotic Golgi Reassembly

    by Tianzhui Liao, Ruotong Li, Ping Lu, Yusong Liu, Rong Yang, Hao Guo, Zhuoxi Wu, Ruiwen Wang, Ling Yuan, Zhengmao Hu, et al.

    The VCPIP1‐P97/VCP (Valosin‐Containing Protein) complex is required for post‐mitotic Golgi cisternae reassembly and maintenance in interphase. However, the organization and mechanism of this complex in regulating Golgi membrane fusion is still elusive. Here, the cryo‐electron microscopy (cryo‐EM) structures of the human VCPIP1‐P97/VCP complex are presented. These studies reveal that three independent VCPIP1 molecules sit over the C‐terminal substrate exit tunnel formed by P97/VCP homo‐hexamer, resulting in an unusual C3 to C6 symmetric barrel architecture. The UFD1 (unknown function domain 1) from VCPIP1, but not the N‐terminal OTU domain and the C‐terminal UBL domain, docks to the two adjacent D2 domains of P97/VCP, allosterically causing the cofactors binding domain‐NTDs (N‐terminal domains) of P97/VCP in a “UP” and D1 domain in an ATPase competent conformation. Conversely, VCPIP1 bound P97/VCP hexamer favors the binding of P47, and thus the intact SNARE complex, promoting Golgi membrane fusion. These studies not only reveal the unexpected organization of humanVCPIP1‐P97/VCP complex, but also provide new insights into the mechanism of VCPIP1‐P97/VCP mediated Golgi apparatus reassembly, which is a fundamental cellular event for protein and lipid processing.


  • Open Access

    The structural basis of the activation and inhibition of DSR2 NADase by phage proteins

    by Ruiwen Wang, Qi Xu, Zhuoxi Wu, Jialu Li, Hao Guo, Tianzhui Liao, Yuan Shi, Ling Yuan, Haishan Gao, Rong Yang, et al.

    DSR2, a Sir2 domain-containing protein, protects bacteria from phage infection by hydrolyzing NAD+. The enzymatic activity of DSR2 is triggered by the SPR phage tail tube protein (TTP), while suppressed by the SPbeta phage-encoded DSAD1 protein, enabling phages to evade the host defense. However, the molecular mechanisms of activation and inhibition of DSR2 remain elusive. Here, we report the cryo-EM structures of apo DSR2, DSR2-TTP-NAD+ and DSR2-DSAD1 complexes. DSR2 assembles into a head-to-head tetramer mediated by its Sir2 domain. The C-terminal helical regions of DSR2 constitute four partner-binding cavities with opened and closed conformation. Two TTP molecules bind to two of the four C-terminal cavities, inducing conformational change of Sir2 domain to activate DSR2. Furthermore, DSAD1 competes with the activator for binding to the C-terminal cavity of DSR2, effectively suppressing its enzymatic activity. Our results provide the mechanistic insights into the DSR2-mediated anti-phage defense system and DSAD1-dependent phage immune evasion.


  • Open Access

    Structural and functional insights into the helicase protein E5 of Mpox virus

    by Weizhen Zhang, Yusong Liu, Mengquan Yang, Jie Yang, Zhiwei Shao, Yanqing Gao, Xinran Jiang, Ruixue Cui, Yixi Zhang, Xin Zhao, et al.

    Mpox virus (MPXV) can cause mpox in humans. Due to its quick and wide spread in the past two years, mpox has turned into a significant public health concern. Helicase E5 is a multi-domain protein; its primer synthesis and DNA unwinding activity are required for genome uncoating and DNA replication of MPXV. However, the in vitro DNA unwinding activity has never been demonstrated. Here, we report the structural and biochemical studies of MPXV E5, showing that the full-length protein adopts an auto-inhibited conformation. Truncation of the N-terminus can recover the in vitro unwinding activity of E5 towards the forked DNA. Further structural analysis reveals that MPXV E5 shares a conserved mechanism in DNA unwinding and primer synthesis with the homologous proteins. These findings not only advance our understanding on the function of MPXV E5, but also provide a solid basis for the development of anti-poxvirus drugs.


  • Open Access

    The structural basis of DSAD1-DSR2 mediated phage immune evasion

    by Faxiang Li, Ruiwen Wang, Qi Xu, Zhuoxi Wu, Jialu Li, Hao Guo, Tianzhui Liao, Yuan Shi, Ling Yuan, Haishan Gao, et al.

    DSR2 belongs to the family of defense-associated sirtuins (DSRs) which protect bacteria from phage infection by hydrolyzing NAD+. Phage propagation is effectively inhibited through the induction of abortive infection by depleting this essential molecule. The enzymatic activity of DSR2 is triggered by the tail tube protein of phages, enabling its functional activation. To escape bacterial immunity, certain phages have evolved to encode DSAD1 protein, which binds to and deactivates DSR2, neutralizing its defensive capabilities. However, the structural basis underlying the degradation of NAD+ by DSR2 and the inhibitory mechanism of its NADase activity by DSAD1 remain elusive. Here, we report the cryo-EM structures of apo DSR2 from Bacillus subtilis and the DSR2-DSAD1 complex. The apo structure reveals that DSR2 assembles into a head-to-head tetramer, which is mediated by its N-terminal Sir2 domain. DSR2 Sir2 domain possesses the highly conserved residues that have been found to be essential for NAD+ coordination and depletion in ThsA. The structures of DSR2-DSAD1 complex demonstrate the binding of two DSAD1 molecules to the two of four C-terminal helical regions of DSR2 tetramer, forming a hetero-hexameric complex. Two DSAD1 protomers locate separately at two ends of DSR2 tetramer either on the same side or opposite sides. This binding at DSR2 C-terminus induces a conformational change in the Sir2 domain at its N-terminus, potentially suppressing its enzymatic activity. These findings not only broaden our understanding of the DSR2-mediated anti-phage defense system, but also uncover the mechanism of DSAD1-dependent phage immune evasion.